Faculty Opinions recommendation of A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.
Heeney, MatthewPediatric Blood Disorders Center, Boston Children’s Hospital, USA
Renella, Raffaele
ORCID
Département Médico-Chirurgical de Pédiatrie, CHUV Centre Hospitalier Universitaire Vaudois, Switzerland
Published in:
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. - Faculty Opinions Ltd. - 2012